BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36555578)

  • 1. Tissue-Protective and Anti-Inflammatory Landmark of PRP-Treated Mesenchymal Stromal Cells Secretome for Osteoarthritis.
    Ragni E; Perucca Orfei C; De Luca P; Libonati F; de Girolamo L
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted Factors and Extracellular Vesicles Account for the Immunomodulatory and Tissue Regenerative Properties of Bone-Marrow-Derived Mesenchymal Stromal Cells for Osteoarthritis.
    Ragni E; Perucca Orfei C; de Girolamo L
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
    Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
    Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage Protective and Immunomodulatory Features of Osteoarthritis Synovial Fluid-Treated Adipose-Derived Mesenchymal Stem Cells Secreted Factors and Extracellular Vesicles-Embedded miRNAs.
    Ragni E; Colombini A; Viganò M; Libonati F; Perucca Orfei C; Zagra L; de Girolamo L
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of Secreted Factors and Extracellular Vesicles-Embedded miRNAs from Bone Marrow-Derived Mesenchymal Stromal Cells in Presence of Synovial Fluid from Osteoarthritis Patients.
    Ragni E; Perucca Orfei C; Valli F; Zagra L; de Girolamo L
    Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36358333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.
    Ragni E; Papait A; Perucca Orfei C; Silini AR; Colombini A; Viganò M; Libonati F; Parolini O; de Girolamo L
    Stem Cells Transl Med; 2021 Jul; 10(7):1044-1062. PubMed ID: 33656805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Controls for the Evaluation of Osteoarthritis-Related miRNAs in Extracellular Vesicles from Bone-Marrow-Derived Mesenchymal Stromal Cells and the Impact of Osteoarthritis Synovial Fluid.
    Ragni E; Perucca Orfei C; Viganò M; Valli F; de Girolamo L
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of osteoarthritis progression through intra-articular injection of a combination of synovial membrane-derived MSCs (SMMSCs), platelet-rich plasma (PRP) and conditioned medium (secretome).
    Nabavizadeh SS; Talaei-Khozani T; Zarei M; Zare S; Hosseinabadi OK; Tanideh N; Daneshi S
    J Orthop Surg Res; 2022 Feb; 17(1):102. PubMed ID: 35177103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Factors and EV-miRNAs Orchestrate the Healing Capacity of Adipose Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis.
    Ragni E; Perucca Orfei C; De Luca P; Colombini A; Viganò M; de Girolamo L
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint Tissue Protective and Immune-Modulating miRNA Landscape of Mesenchymal Stromal Cell-Derived Extracellular Vesicles under Different Osteoarthritis-Mimicking Conditions.
    Ragni E; Perucca Orfei C; Sinigaglia F; de Girolamo L
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel kartogenin-platelet-rich plasma gel enhances chondrogenesis of bone marrow mesenchymal stem cells in vitro and promotes wounded meniscus healing in vivo.
    Liu F; Xu H; Huang H
    Stem Cell Res Ther; 2019 Jul; 10(1):201. PubMed ID: 31287023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytes.
    Ragni E; Perucca Orfei C; De Luca P; Lugano G; Viganò M; Colombini A; Valli F; Zacchetti D; Bollati V; de Girolamo L
    Stem Cell Res Ther; 2019 Mar; 10(1):109. PubMed ID: 30922413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoarthritic cartilage explants affect extracellular matrix production and composition in cocultured bone marrow-derived mesenchymal stem cells and articular chondrocytes.
    Leyh M; Seitz A; Dürselen L; Springorum HR; Angele P; Ignatius A; Grifka J; Grässel S
    Stem Cell Res Ther; 2014 Jun; 5(3):77. PubMed ID: 24916039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.
    Sundman EA; Cole BJ; Karas V; Della Valle C; Tetreault MW; Mohammed HO; Fortier LA
    Am J Sports Med; 2014 Jan; 42(1):35-41. PubMed ID: 24192391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage.
    Moussa M; Lajeunesse D; Hilal G; El Atat O; Haykal G; Serhal R; Chalhoub A; Khalil C; Alaaeddine N
    Exp Cell Res; 2017 Mar; 352(1):146-156. PubMed ID: 28202394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory potential of secretome from cartilage cells and mesenchymal stromal cells in an arthritic context: From predictive fiction toward reality.
    Colombini A; Libonati F; Lopa S; Ragni E; De Luca P; Zagra L; Sinigaglia F; Moretti M; de Girolamo L
    Front Med (Lausanne); 2022; 9():992386. PubMed ID: 36314003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design: in vitro and in vivo assessment of bone morphogenic protein 2 combined with platelet-rich plasma on treatment of disc degeneration.
    Hou Y; Shi G; Shi J; Xu G; Guo Y; Xu P
    Int Orthop; 2016 Jun; 40(6):1143-55. PubMed ID: 26169838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model.
    Khatab S; van Osch GJ; Kops N; Bastiaansen-Jenniskens YM; Bos PK; Verhaar JA; Bernsen MR; van Buul GM
    Eur Cell Mater; 2018 Nov; 36():218-230. PubMed ID: 30398288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy.
    Chen WH; Lo WC; Hsu WC; Wei HJ; Liu HY; Lee CH; Tina Chen SY; Shieh YH; Williams DF; Deng WP
    Biomaterials; 2014 Dec; 35(36):9599-607. PubMed ID: 25176059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy free of cells vs human mesenchymal stem cells from umbilical cord stroma to treat the inflammation in OA.
    Morente-López M; Mato-Basalo R; Lucio-Gallego S; Silva-Fernández L; González-Rodríguez A; De Toro FJ; Fafián-Labora JA; Arufe MC
    Cell Mol Life Sci; 2022 Oct; 79(11):557. PubMed ID: 36264388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.